
Reliance Industries (RELIANCE) Stock Analyst Review May 2026
Fri May 15 2026

This Reliance Industries analyst review for May 2026 covers everything investors need to assess RELIANCE at Rs 1,360. Reliance Industries (NSE: RELIANCE) is India’s most valuable company with a market capitalisation of Rs 18,45,838 crore, operating across Jio Platforms, Reliance Retail, Oil-to-Chemicals (O2C), and New Energy. The 32-analyst consensus target of Rs 1,697 implies roughly 25 percent upside, making this Reliance Industries analyst review critical for investors deciding whether to accumulate or hold.
Click Here – Get Free Investment Predictions
Reliance Industries Company Snapshot May 2026
This Reliance Industries analyst review is based on live market data as of May 2026, incorporating the latest quarterly results and analyst consensus targets for Reliance Industries (NSE: RELIANCE), one of India’s largest companies in the Diversified Conglomerate sector.
| Parameter | Value |
|---|---|
| NSE Ticker | RELIANCE |
| Sector | Diversified Conglomerate |
| CMP (May 2026) | Rs 1,360 |
| 52 Week High | Rs 1,611.80 |
| 52 Week Low | Rs 1,290 |
| Market Cap | Rs 18,45,838 Crore |
| Trailing P/E | 22.76x |
| Analyst Consensus Target | Rs 1,697 |
| Bull Case Target | Rs 1,910 |
| Bear Case Target | Rs 1,150 |
Latest Results and Business Performance
Q4 FY26 results declared April 24, 2026 showed consolidated revenue rising 12.9 percent YoY to Rs 2,94,059 crore. Net profit declined 12.55 percent YoY to Rs 16,971 crore due to O2C weakness from West Asia geopolitical disruptions. Full-year FY26 net profit grew 15.98 percent to Rs 80,775 crore. This Reliance Industries analyst review notes that Jio and Retail contributed over 55 percent of consolidated EBITDA for the first time in FY26, confirming the structural shift to a consumer-led conglomerate. A record Rs 6 per share dividend was declared for FY26.
Screen the best stocks on the Univest Screener.
Segment and Business Analysis in This Reliance Industries Analyst Review
Jio Platforms
Jio crossed 524 million subscribers in FY26 with revenue of Rs 1,46,885 crore, up 14.6 percent YoY, and EBITDA of Rs 76,255 crore at a 52 percent margin. ARPU is trending toward Rs 200 with FY27 estimates of Rs 220 to 240 through premium plan migration. The Jio Platforms IPO targeting Rs 50,000 crore is the most material value unlock in this Reliance Industries analyst review.
Reliance Retail
Retail crossed Rs 3,70,026 crore in FY26 revenue, up 12 percent YoY, with EBITDA of Rs 27,033 crore. The segment served 387 million customers across 20,160 stores, and hyperlocal commerce orders surged 300 percent YoY.
O2C Segment
O2C EBITDA declined 3.7 percent YoY to Rs 14,520 crore in Q4 due to geopolitical disruptions and higher crude freight costs. Recovery in FY27 as West Asia tensions ease is a key watch point in this Reliance Industries analyst review.
Valuation and Analyst Price Targets
At Rs 1,360, RELIANCE trades at 22.76x P/E. The 32-analyst consensus target of Rs 1,697 implies 25 percent upside. Thirty-one of 32 analysts carry a Buy rating, making this one of the highest conviction large-cap calls in this Reliance Industries analyst review.
| Scenario | Target Price |
|---|---|
| Bull Case | Rs 1,910 |
| Base Case (Consensus) | Rs 1,697 |
| Bear Case | Rs 1,150 |
Screen the best stocks on the Univest Screener.
Key Catalysts for Reliance Industries in FY27
The Jio Platforms IPO at USD 200 to 240 billion estimated enterprise value is the primary catalyst in this Reliance Industries analyst review. Additional drivers include ARPU improving to Rs 220 to 240 in FY27, O2C margin recovery as geopolitical pressures ease, New Energy revenue contribution from solar manufacturing, and the RBI rate cut cycle reducing borrowing costs.
Key Risks in This Reliance Industries Analyst Review
Key risks in this Reliance Industries analyst review include prolonged West Asia conflict sustaining O2C margin suppression, continued FII outflows from US tariff macro uncertainty, a Jio IPO delay beyond FY27, adverse telecom regulatory changes, and Retail margin deterioration from hyperlocal commerce investment costs.
Download the Univest iOS App or the Univest Android App to get daily stock recommendations and expert research.
Conclusion: Reliance Industries Analyst Review Verdict
This Reliance Industries analyst review concludes that at Rs 1,360 with a 32-analyst strong-buy consensus and a Rs 1,697 target, the risk-reward is asymmetrically positive for long-term investors. FY26 net profit grew 15.98 percent and Jio plus Retail are compounding at double-digit rates. The Rs 1,290 to 1,400 zone represents a structured accumulation opportunity per this Reliance Industries analyst review. Always consult a SEBI-registered financial advisor before making any investment decisions.
Frequently Asked Questions on Reliance Industries Analyst Review 2026
What is the analyst consensus target for Reliance Industries in 2026?
The 32-analyst consensus target is Rs 1,697, with a bull case of Rs 1,910. This Reliance Industries analyst review notes that 31 of 32 analysts carry a Buy rating as of May 2026.
Why did Reliance Q4 FY26 profit decline?
Net profit fell 12.55 percent YoY to Rs 16,971 crore due to O2C weakness from West Asia disruptions. Full-year FY26 net profit grew 15.98 percent, as tracked in this Reliance Industries analyst review.
Is Reliance Industries a good buy in 2026?
At Rs 1,360 with 25 percent upside to consensus target, this Reliance Industries analyst review is constructive for long-term investors. Consult a SEBI-registered advisor before investing.
What is Jio’s subscriber base and ARPU?
Jio crossed 524 million subscribers in FY26. ARPU is trending toward Rs 200 with FY27 estimates of Rs 220 to 240, the core growth driver in this Reliance Industries analyst review.
What dividend did Reliance declare for FY26?
Reliance declared Rs 6 per share, its highest-ever dividend. This capital return record is a key positive in this Reliance Industries analyst review.
Investments in securities are subject to market risk. This content is for educational purposes only and does not constitute investment advice. Please consult a SEBI-registered financial advisor before making any investment decisions.
Related Posts
Biogen Pharmachem Industries Q4 FY26 Results: Announced May 14 2026 Pharmaceuticals – APIs and Formulations
Walchand Peoplefirst Q4 FY26 Results: Announced May 14 2026 Learning and Development – Corporate Training
Abhinav Capital Services Q4 FY26 Results: Announced May 14 2026 NBFC – Financial Services
Cubical Financial Services Q4 FY26 Results: Announced May 14 2026 Financial Advisory and Investment Services
Vani Commercials Q4 FY26 Results: Announced May 14 2026 Financial Services and Investments

Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited
Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003
Write to us : support@univest.in, compliance@univest.in
Verify on SEBI registry →